|
1
|
de Vega S, Iwamoto T and Yamada Y:
Fibulins: Multiple roles in matrix structures and tissue functions.
Cell Mol Life Sci. 66:1890–1902. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yanagisawa H and Davis EC: Unraveling the
mechanism of elastic fiber assembly: The roles of short fibulins.
Int J Biochem Cell Biol. 42:1084–1093. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Papke CL and Yanagisawa H: Fibulin-4 and
fibulin-5 in elastogenesis and beyond: Insights from mouse and
human studies. Matrix Biol. 37:142–149. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Albig AR and Schiemann WP: Fibulin-5
function during tumorigenesis. Future Oncol. 1:23–35. 2005.
View Article : Google Scholar
|
|
5
|
Lomas AC, Mellody KT, Freeman LJ, Bax DV,
Shuttleworth CA and Kielty CM: Fibulin-5 binds human smooth-muscle
cells through alpha5beta1 and alpha4beta1 integrins, but does not
support receptor activation. Biochem J. 405:417–428. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yanagisawa H, Davis EC, Starcher BC, Ouchi
T, Yanagisawa M, Richardson JA and Olson EN: Fibulin-5 is an
elastin-binding protein essential for elastic fibre development in
vivo. Nature. 415:168–171. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Stone EM, Braun TA, Russell SR, Kuehn MH,
Lotery AJ, Moore PA, Eastman CG, Casavant TL and Sheffield VC:
Missense variations in the fibulin 5 gene and age-related macular
degeneration. N Engl J Med. 351:346–353. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jones RP, Ridley C, Jowitt TA, Wang MC,
Howard M, Bobola N, Wang T, Bishop PN, Kielty CM, Baldock C, et al:
Structural effects of fibulin 5 missense mutations associated with
age-related macular degeneration and cutis laxa. Invest Ophthalmol
Vis Sci. 51:2356–2362. 2010. View Article : Google Scholar :
|
|
9
|
Gallagher WM, Currid CA and Whelan LC:
Fibulins and cancer: Friend or foe? Trends Mol Med. 11:336–340.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Obaya AJ, Rua S, Moncada-Pazos A and Cal
S: The dual role of fibulins in tumorigenesis. Cancer Lett.
325:132–138. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hwang CF, Shiu LY, Su LJ, Yin Yu-Fang,
Wang WS, Huang SC, Chiu TJ, Huang CC, Zhen YY, Tsai HT, et al:
Oncogenic fibulin-5 promotes nasopharyngeal carcinoma cell
metastasis through the FLJ10540/AKT pathway and correlates with
poor prognosis. PLoS One. 8:e842182013. View Article : Google Scholar
|
|
12
|
Ohara H, Akatsuka S, Nagai H, Liu YT,
Jiang L, Okazaki Y, Yamashita Y, Nakamura T and Toyokuni S:
Stage-specific roles of fibulin-5 during oxidative stress-induced
renal carcinogenesis in rats. Free Radic Res. 45:211–220. 2011.
View Article : Google Scholar
|
|
13
|
Lee YH, Albig AR, Regner M, Schiemann BJ
and Schiemann WP: Fibulin-5 initiates epithelial-mesenchymal
transition (EMT) and enhances EMT induced by TGF-beta in mammary
epithelial cells via a MMP-dependent mechanism. Carcinogenesis.
29:2243–2251. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xiao W, Zhou S, Xu H, Li H, He G, Liu Y
and Qi Y: Nogo-B promotes the epithelial-mesenchymal transition in
HeLa cervical cancer cells via Fibulin-5. Oncol Rep. 29:109–116.
2013.
|
|
15
|
Hu Z, Ai Q, Xu H, Ma X, Li HZ, Shi TP,
Wang C, Gong DJ and Zhang X: Fibulin-5 is down-regulated in
urothelial carcinoma of bladder and inhibits growth and invasion of
human bladder cancer cell line 5637. Urol Oncol. 29:430–435. 2011.
View Article : Google Scholar
|
|
16
|
Yue W, Sun Q, Landreneau R, Wu C,
Siegfried JM, Yu J and Zhang L: Fibulin-5 suppresses lung cancer
invasion by inhibiting matrix metalloproteinase-7 expression.
Cancer Res. 69:6339–6346. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen X, Song X, Yue W, Chen D, Yu J, Yao Z
and Zhang L: Fibulin-5 inhibits Wnt/β-catenin signaling in lung
cancer. Oncotarget. 6:15022–15034. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xie L, Palmsten K, MacDonald B, Kieran MW,
Potenta S, Vong S and Kalluri R: Basement membrane derived
fibulin-1 and fibulin-5 function as angiogenesis inhibitors and
suppress tumor growth. Exp Biol Med (Maywood). 233:155–162. 2008.
View Article : Google Scholar
|
|
19
|
Albig AR, Neil JR and Schiemann WP:
Fibulins 3 and 5 antagonize tumor angiogenesis in vivo. Cancer Res.
66:2621–2629. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wlazlinski A, Engers R, Hoffmann MJ, Hader
C, Jung V, Müller M and Schulz WA: Downregulation of several
fibulin genes in prostate cancer. Prostate. 67:1770–1780. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Inwald EC, Klinkhammer-Schalke M,
Hofstädter F, Zeman F, Koller M, Gerstenhauer M and Ortmann O:
Ki-67 is a prognostic parameter in breast cancer patients: Results
of a large population-based cohort of a cancer registry. Breast
Cancer Res Treat. 139:539–552. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Schiemann WP, Blobe GC, Kalume DE, Pandey
A and Lodish HF: Context-specific effects of fibulin-5 (DANCE/EVEC)
on cell proliferation, motility, and invasion. Fibulin-5 is induced
by transforming growth factor-beta and affects protein kinase
cascades. J Biol Chem. 277:27367–27377. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Rhodes LV, Antoon JW, Muir SE, Elliott S,
Beckman BS and Burow ME: Effects of human mesenchymal stem cells on
ER-positive human breast carcinoma cells mediated through
ER-SDF-1/CXCR4 crosstalk. Mol Cancer. 9:2952010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Dontu G, Abdallah WM, Foley JM, Jackson
KW, Clarke MF, Kawamura MJ and Wicha MS: In vitro propagation and
transcriptional profiling of human mammary stem/progenitor cells.
Genes Dev. 17:1253–1270. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Győrffy B, Benke Z, Lánczky A, Balázs B,
Szállási Z, Timár J and Schäfer R: RecurrenceOnline: An online
analysis tool to determine breast cancer recurrence and hormone
receptor status using microarray data. Breast Cancer Res Treat.
132:1025–1034. 2012. View Article : Google Scholar
|
|
26
|
Manuel Iglesias J, Beloqui I,
Garcia-Garcia F, Leis O, Vazquez-Martin A, Eguiara A, Cufi S, Pavon
A, Menendez JA, Dopazo J, et al: Mammosphere formation in breast
carcinoma cell lines depends upon expression of E-cadherin. PLoS
One. 8:e772812013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kelly T, Yan Y, Osborne RL, Athota AB,
Rozypal TL, Colclasure JC and Chu WS: Proteolysis of extracellular
matrix by invadopodia facilitates human breast cancer cell invasion
and is mediated by matrix metalloproteinases. Clin Exp Metastasis.
16:501–512. 1998. View Article : Google Scholar
|
|
28
|
Schluterman MK, Chapman SL, Korpanty G,
Ozumi K, Fukai T, Yanagisawa H and Brekken RA: Loss of fibulin-5
binding to beta1 integrins inhibits tumor growth by increasing the
level of ROS. Dis Model Mech. 3:333–342. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Heo JH, Song JY, Jeong JY, Kim G, Kim TH,
Kang H, Kwon AY and An HJ: Fibulin-5 is a tumour suppressor
inhibiting cell migration and invasion in ovarian cancer. J Clin
Pathol. jclinpath-2015-203129. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang K, Corsa CA, Ponik SM, Prior JL,
Piwnica-Worms D, Eliceiri KW, Keely PJ and Longmore GD: The
collagen receptor discoidin domain receptor 2 stabilizes SNAIL1 to
facilitate breast cancer metastasis. Nat Cell Biol. 15:677–687.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Cai J, Guan H, Fang L, Yang Y, Zhu X, Yuan
J, Wu J and Li M: MicroRNA-374a activates Wnt/β-catenin signaling
to promote breast cancer metastasis. J Clin Invest. 123:566–579.
2013.PubMed/NCBI
|
|
32
|
Klemm F, Bleckmann A, Siam L, Chuang HN,
Rietkötter E, Behme D, Schulz M, Schaffrinski M, Schindler S,
Trümper L, et al: β-catenin-independent WNT signaling in basal-like
breast cancer and brain metastasis. Carcinogenesis. 32:434–442.
2011. View Article : Google Scholar
|
|
33
|
Laezza C, D'Alessandro A, Paladino S,
Maria Malfitano A, Chiara Proto M, Gazzerro P, Pisanti S, Santoro
A, Ciaglia E and Bifulco M; Endocannabinoid Research Group.
Anandamide inhibits the Wnt/β-catenin signalling pathway in human
breast cancer MDA MB 231 cells. Eur J Cancer. 48:3112–3122. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Fang D, Hawke D, Zheng Y, Xia Y,
Meisenhelder J, Nika H, Mills GB, Kobayashi R, Hunter T and Lu Z:
Phosphorylation of beta-catenin by AKT promotes beta-catenin
transcriptional activity. J Biol Chem. 282:11221–11229. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Preis M, Cohen T, Sarnatzki Y, Ben Yosef
Y, Schneiderman J, Gluzman Z, Koren B, Lewis BS, Shaul Y and
Flugelman MY: Effects of fibulin-5 on attachment, adhesion, and
proliferation of primary human endothelial cells. Biochem Biophys
Res Commun. 348:1024–1033. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Li F, Xu H, Zeng Y and Yin ZQ:
Overexpression of fibulin-5 in retinal pigment epithelial cells
inhibits cell proliferation and migration and downregulates VEGF,
CXCR4, and TGFB1 expression in cocultured choroidal endothelial
cells. Curr Eye Res. 37:540–548. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Spencer JA, Hacker SL, Davis EC, Mecham
RP, Knutsen RH, Li DY, Gerard RD, Richardson JA, Olson EN and
Yanagisawa H: Altered vascular remodeling in fibulin-5-deficient
mice reveals a role of fibulin-5 in smooth muscle cell
proliferation and migration. Proc Natl Acad Sci USA. 102:2946–2951.
2005. View Article : Google Scholar : PubMed/NCBI
|
